VOTS – Michmutters
Categories
US

Biden signs documents of US support for Sweden, Finland to join NATO

WASHINGTON, Aug 9 (Reuters) – US President Joe Biden on Tuesday signed documents endorsing Finland and Sweden’s accession to NATO, the most significant expansion of the military alliance since the 1990s as it responds to Russia’s invasion of Ukraine.

Biden signed the US “instrument of ratification” welcoming the two countries, the final step for their endorsement by the United States.

“It was and is a watershed moment I believe in the alliance and for the greater security and stability not only of Europe and the United States but of the world,” he said of their entry into the post World War Two alliance.

Register now for FREE unlimited access to Reuters.com

The US Senate backed the expansion by an overwhelming 95-1 last week, a rare display of bipartisan unity in a bitterly divided Washington. Both Democratic and Republican Senators strongly approved membership for the two Nordic countries, describing them as important allies whose modern militaries already worked closely with NATO. read more

The vote was a sharp contrast with some rhetoric in Washington during the administration of former Republican President Donald Trump, who pursued an “America First” foreign policy and criticized NATO allies who failed to reach defense spending targets.

Sweden and Finland applied for NATO membership in response to Russia’s Feb. 24 invasion of Ukraine. Moscow has repeatedly warned both countries against joining the alliance.

Putin is getting “exactly what he did not want,” with the two countries entering the alliance, Biden said.

NATO’s 30 allies signed the accession protocol for Sweden and Finland last month, allowing them to join the nuclear-armed alliance once all member states ratify the decision. read more

The accession must be ratified by the parliaments of all 30 North Atlantic Treaty Organization members before Finland and Sweden can be protected by Article Five, the defense clause stating that an attack on one ally is an attack on all.

Ratification could take up to a year, although the accession has already been approved by a few countries including Canada, Germany and Italy.

Register now for FREE unlimited access to Reuters.com

Reporting by Patricia Zengerle and Jeff Mason Editing by Mark Heinrich and Grant McCool

Our Standards: The Thomson Reuters Trust Principles.

.

Categories
US

US Senate Democrats battle to pass $430 billion climate, drug bill

WASHINGTON, Aug 6 (Reuters) – The US Senate on Saturday began debating a Democratic bill to address key elements of President Joe Biden’s agenda – tackling climate change, lowering the costs of medication for the elderly and energy, while forcing corporations and the wealthy to pay more taxes.

The debate began after the Senate voted 51-50 to move ahead with the legislation. Vice President Kamala Harris broke a tie vote, with all 50 Republicans in opposition.

The Senate was set to debate the bill for up to 20 hours before diving into an arduous, time-consuming amendment process called a “vote-a-rama.”

Register now for FREE unlimited access to Reuters.com

Democrats and Republicans were poised to reject each other’s amendments, as Senate Majority Leader Chuck Schumer maneuvered to keep a his 50-member caucus united behind a bill that was negotiated over several months. If even one Democrat were to peel off, the entire effort would be doomed in the evenly split 50-50 Senate. read more

Earlier in the day, the Senate parliamentarian determined that the lion’s share of the healthcare provisions in the $430 billion bill could be passed with only a simple majority, bypassing a filibuster rule requiring 60 votes in the 100-seat chamber to advance most legislation and enabling Democrats to pass it over Republican objections.

Democrats hope that the legislation will give a boost to their candidates in the Nov. 8 midterm elections in which Biden’s party is in an uphill battle to retain its narrow control of the Senate and House of Representatives. The Democrats cast the legislation as a vehicle to combat inflation, a prime concern of US voters this year.

“The bill, when passed, will meet all of our goals: fighting climate change, lowering healthcare costs, closing tax loopholes abused by the wealthy and reducing the deficit,” Schumer said in a Senate speech.

There are three main parts to the bill’s tax provisions: a 15% minimum tax on corporations and the closing of loopholes that the wealthy can use to avoid paying taxes; tougher IRS enforcement; and a new excise tax on stock buybacks.

The legislation has $430 billion in new spending along with raising more than $740 billion in new revenues. read more

Democrats have said the legislation by 2030 would result in a 40% reduction in US carbon emissions, blamed for climate change.

‘PRICE-FIXING’

The measure would also allow the Medicare government health insurance program for the elderly to begin negotiating in 2026 with the pharmaceutical industry over prices on a limited number of prescription drug prices as a way of reducing costs. It also would place a $2,000-per-year cap on out-of-pocket medication costs under a Medicare drug program.

Senate Republican Leader Mitch McConnell attacked the provision involving negotiating drug prices, comparing it to past “price-fixing” attempts by countries such as Cuba, Venezuela and the former Soviet Union.

“Their policy would bring about a world where many fewer new drugs and treatments get invented in the first place as companies cut back on R&D,” McConnell said in a floor speech, referring to research and development.

While senators debated the policies embedded in the bill, its political ramifications were also on display.

In a speech at the Conservative Political Action Conference (CPAC) on Saturday, former President Donald Trump predicted fallout for Kyrsten Sinema and Joe Manchin, two key Democratic senators: “If this deal passes, they are both going to lose their next elections.”

But Manchin and Sinema are not up for re-election until 2024 and many of the provisions of the bill are popular with voters.

The legislation is a scaled-down version of a far broader, more expensive measure that many Democrats on the party’s left had hoped to approve last year. That measure stalled when Manchin, a centrist, balked, complaining that it would exacerbate inflationary pressures.

The bill calls for billions of dollars to encourage the production of more electric vehicles and foster clean energy, though automakers say sourcing rules will sharply limit how many electric vehicles qualify for tax credits.

It would also set $4 billion in new federal drought relief funds, a provision that could help the re-election campaigns of Democratic Senators Catherine Cortez Masto in Nevada and Mark Kelly in Arizona.

One provision cut from the bill would have forced drug companies to refund money to both government and private health plans if drug prices rise more quickly than inflation.

Independent Senator Bernie Sanders, a leading progressive, has criticized the bill for failing to go far enough and said he planned to offer amendments that would revive a series of social programs he pushed last year, including broadening the number of prescription drugs Medicare could negotiate prices on and providing government-subsidized dental, vision and hearing aid.

His amendments were expected to fail.

Republicans have signaled that they will offer amendments touching on other issues, including controlling immigrants coming across the US border with Mexico and enhancing policing to curtail rising crime rates in American cities since the onset of the COVID-19 pandemic.

Register now for FREE unlimited access to Reuters.com

Reporting by Richard Cowan and Makini Brice; additional reporting by Valerie Volcovici, David Shepardson and Kanishka Singh; Editing by Will Dunham, Scott Malone and Lisa Shumaker

Our Standards: The Thomson Reuters Trust Principles.

.

Categories
US

Key US Senator Sinema agrees to $430 billion drug, energy bill

WASHINGTON, Aug 4 (Reuters) – Democratic US Senator Kyrsten Sinema said on Thursday she agreed to “move forward” on a $430 billion drug pricing, energy and tax bill, subject to a Senate arbitrator’s approval of the bill, which Democrats intend to pass over Republican objections.

Senate Majority Leader Chuck Schumer said earlier on Thursday the chamber would convene on Saturday to vote on a motion to proceed and then begin debate on the bill.

The bill known as the Inflation Reduction Act, introduced last week by Schumer and Democratic Senator Joe Manchin, is a key priority for Democrats and President Joe Biden ahead of November’s election battle for control of the US Congress.

Register now for FREE unlimited access to Reuters.com

The act will help people save money on prescription drugs and health premiums, Biden said in a statement on Thursday.

“It will make our tax system more fair by making corporations pay a minimum tax,” he said.

With the 100-seat Senate split 50-50, Democrats plan to pass the bill without Republican support through a parliamentary process known as reconciliation.

But they cannot afford to lose support from a single lawmaker. Sinema’s agreement was a critical breakthrough. Another worry is COVID-19 – senators can only vote in person, so Schumer will need his full caucus to be present and healthy to pass the measure if Republicans remain unified in opposition.

Sinema said she had reached an agreement with other Democrats to remove a provision that would impose new taxes on carried interest. Without the provision, private equity and hedge fund financiers can continue to pay the lower capital gains tax rate on much of their income, instead of the higher income tax rate paid by wage-earners.

She cautioned that her agreement to “move forward” was subject to the review of the Senate parliamentarian. The parliamentarian has to approve the contents of the bill to allow it to move forward through the “reconciliation” process that Democrats plan to use to bypass the chamber’s normal rules requiring 60 Senators to agree to advance most legislation.

Schumer, in a statement, said, he believed he now had the votes to pass the bill.

“The agreement preserves the major components of the Inflation Reduction Act, including reducing prescription drug costs, fighting climate change, closing tax loopholes exploited by big corporations and the wealthy, and reducing the deficit by $300 billion,” Schumer said.

Register now for FREE unlimited access to Reuters.com

Reporting by Scott Malone, Additional reporting by Shivani Tanna in Bengaluru; Editing by Daniel Wallis, Shri Navaratnam and Tom Hogue

Our Standards: The Thomson Reuters Trust Principles.

.